ADH1B encodes an alcohol dehydrogenase enzyme. Variants like rs1229984 (ADH1B*2) accelerate ethanol-to-acetaldehyde conversion, associated with lower alcohol intake and reduced type 2 diabetes risk. However, the effect is indirect: carriers tend to drink less, which may improve blood sugar. Direct effects on glucose metabolism are not clearly proven. Evidence comes mainly from GWAS and epidemiological studies; randomized controlled trials are lacking. Effect size varies by ancestry. A genetic test alone cannot predict personal diabetes risk – lifestyle, diet, and exercise are far more important. If you carry the variant, still moderate alcohol consumption, as the protective effect is not guaranteed. Increased risk for other conditions (e.g., liver disease) remains. Bottom line: ADH1B is an interesting but non-deterministic marker. Do not be misled by commercial tests into false reassurance.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-722d7add8c314d15c0138c12